Benjamin L Walter

Prof. Benjamin L Walter

Cleveland Clinic, Cleveland, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in The Lancet
Verified
Journal Article
Open access
AAA Bolu Ajiboye
A Bolu Ajiboye
FWFrancis R Willett
Francis R Willett
DYDaniel R Young
Daniel R Young
WMWilliam D Memberg
William D Memberg
BMBrian A Murphy
Brian A Murphy
RKRobert F Kirsch
Robert F Kirsch
People with chronic tetraplegia, due to high-cervical spinal cord injury, can regain limb movements through coordinated electrical stimulation of peripheral muscles and nerves, known as functional electrical stimulation (FES). Users typically command FES systems through other preserved, but unrelated and limited in number, volitional movements (eg, facial muscle activity, head movements, shoulder shrugs). We report the findings of an individual with traumatic high-cervical spinal cord injury who coordinated reaching and grasping movements using his own paralysed arm and hand, reanimated through implanted FES, and commanded using his own cortical signals through an intracortical brain-computer interface (iBCI). We recruited a participant into the BrainGate2 clinical trial, an ongoing study that obtains safety information regarding an intracortical neural interface device, and investigates the feasibility of people with tetraplegia controlling assistive devices using their cortical signals. Surgical procedures were performed at University Hospitals Cleveland Medical Center (Cleveland, OH, USA). Study procedures and data analyses were performed at Case Western Reserve University (Cleveland, OH, USA) and the US Department of Veterans Affairs, Louis Stokes Cleveland Veterans Affairs Medical Center (Cleveland, OH, USA). The study participant was a 53-year-old man with a spinal cord injury (cervical level 4, American Spinal Injury Association Impairment Scale category A). He received two intracortical microelectrode arrays in the hand area of his motor cortex, and 4 months and 9 months later received a total of 36 implanted percutaneous electrodes in his right upper and lower arm to electrically stimulate his hand, elbow, and shoulder muscles. The participant used a motorised mobile arm support for gravitational assistance and to provide humeral abduction and adduction under cortical control. We assessed the participant's ability to cortically command his paralysed arm to perform simple single-joint arm and hand movements and functionally meaningful multi-joint movements. We compared iBCI control of his paralysed arm with that of a virtual three-dimensional arm. This study is registered with ClinicalTrials.gov, number NCT00912041. The intracortical implant occurred on Dec 1, 2014, and we are continuing to study the participant. The last session included in this report was Nov 7, 2016. The point-to-point target acquisition sessions began on Oct 8, 2015 (311 days after implant). The participant successfully cortically commanded single-joint and coordinated multi-joint arm movements for point-to-point target acquisitions (80-100% accuracy), using first a virtual arm and second his own arm animated by FES. Using his paralysed arm, the participant volitionally performed self-paced reaches to drink a mug of coffee (successfully completing 11 of 12 attempts within a single session 463 days after implant) and feed himself (717 days after implant). To our knowledge, this is the first report of a combined implanted FES+iBCI neuroprosthesis for restoring both reaching and grasping movements to people with chronic tetraplegia due to spinal cord injury, and represents a major advance, with a clear translational path, for clinically viable neuroprostheses for restoration of reaching and grasping after paralysis. National Institutes of Health, Department of Veterans Affairs.

5 December 2014 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
LSLauren E. Schrock
Lauren E. Schrock
JMJonathan W. Mink
Jonathan W. Mink
DWDouglas W. Woods
Douglas W. Woods
MPMauro Porta
Mauro Porta
DSDomenico Servello
Domenico Servello
TGTourette Syndrome Association International Deep Brain Stimulation (DBS) Database and Registry Study Group
Tourette Syndrome Association International Deep Brain Stimulation (DBS) Database and Registry Study Group

1 January 2004 in Journal Of Clinical Neurophysiology
Verified
Journal Article
Closed access
CMCameron C. McIntyre
Cameron C. McIntyre
MSMarc Savasta
Marc Savasta
BWBenjamin L Walter
Benjamin L Walter
JVJerrold L. Vitek
Jerrold L. Vitek
High-frequency deep brain stimulation (DBS) of the thalamus or basal ganglia represents an effective clinical technique for the treatment of several medically refractory movement disorders (e.g., Parkinson’s disease, essential tremor, and dystonia). In addition, new clinical applications of DBS for other neurologic and psychiatric disorders (e.g., epilepsy and obsessive-compulsive disorder) have been vaulted forward. Although DBS has been effective in the treatment of movement disorders and is rapidly being explored for the treatment of other neurologic disorders, the scientific understanding of its mechanisms of action remains unclear and continues to be debated in the scientific community. Optimization of DBS technology for present and future therapeutic applications will depend on identification of the therapeutic mechanism(s) of action. The goal of this review is to address the present knowledge of the effects of high frequency stimulation within the central nervous system and comment on the functional implications of this knowledge for uncovering the mechanism(s) of DBS. Four general hypotheses have been developed to explain the mechanism(s) of DBS: depolarization blockade, synaptic inhibition, synaptic depression, and stimulation-induced modulation of pathologic network activity. Using the results from microdialysis, neural recording, functional imaging, and neural modeling experiments, the authors address the main hypotheses and attempt to reconcile what have been considered conflicting results from different research modalities.

1 March 2018 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
DMDaniel Martinez-Ramirez
Daniel Martinez-Ramirez
JJJoohi Jimenez-Shahed
Joohi Jimenez-Shahed
JLJames Frederick Leckman
James Frederick Leckman
MPMauro Porta
Mauro Porta
DSDomenico Servello
Domenico Servello
MOMichael S. Okun
Michael S. Okun
Surgical therapies for Tourette syndrome have been used since the early 1960s. Ablative procedures were initially used to target specific areas of the brain; these approaches revealed inconsistent, but in many cases reasonably positive, clinical outcomes, particularly on motor tics. Ablative surgical procedures did not become mainstream and largely disappeared from the treatment arsenal for Tourette syndrome.1 Deep brain stimulation (DBS) for Tourette syndrome, introduced in 1999,2 is a surgical therapy that uses an implantable device to deliver electrical stimulation to specific and carefully targeted brain structures. Deep brain stimulation is approved by the US Food and Drug Administration and Conformité Européene Mark approved in the European Union for the treatment of selected cases of Parkinson disease and essential tremor. Deep brain stimulation has a Conformité Européene Mark for selected cases of primary and secondary dystonia.3 Deep brain stimulation also received approval from the US Food and Drug Administration under a humanitarian device exemption for dystonia and obsessive-compulsive disorder.4 Although DBS is not approved for Tourette syndrome in the United States and other countries, multiple single reports and case series have collectively demonstrated that DBS could be a potentially valuable therapy for select cases of severe medication-resistant Tourette syndrome. A recent systematic review and meta-analysis of 57 studies including 156 cases of DBS for Tourette syndrome reported an overall improvement of 53% as measured by the total Yale Global Tic Severity Scale (YGTSS) score.5

10 April 2008 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
CMC B Maks
C B Maks
CBChristopher R Butson
Christopher R Butson
BWBenjamin L Walter
Benjamin L Walter
JVJ L Vitek
J L Vitek
CMC C McIntyre
C C McIntyre
Objective: Despite the clinical success of deep brain stimulation (DBS) for the treatment of Parkinson’s disease (PD), little is known about the electrical spread of the stimulation. The primary goal of this study was to integrate neuroimaging, neurophysiology and neurostimulation data sets from 10 patients with PD, unilaterally implanted with subthalamic nucleus (STN) DBS electrodes, to identify the theoretical volume of tissue activated (VTA) by clinically defined therapeutic stimulation parameters. Methods: Each patient specific model was created with a series of five steps: (1) definition of the neurosurgical stereotactic coordinate system within the context of preoperative imaging data; (2) entry of intraoperative microelectrode recording locations from neurophysiologically defined thalamic, subthalamic and substantia nigra neurons into the context of the imaging data; (3) fitting a three dimensional brain atlas to the neuroanatomy and neurophysiology of the patient; (4) positioning the DBS electrode in the documented stereotactic location, verified by postoperative imaging data; and (5) calculation of the VTA using a diffusion tensor based finite element neurostimulation model. Results: The patient specific models show that therapeutic benefit was achieved with direct stimulation of a wide range of anatomical structures in the subthalamic region. Interestingly, of the five patients exhibiting a greater than 40% improvement in their Unified PD Rating Scale (UPDRS), all but one had the majority of their VTA outside the atlas defined borders of the STN. Furthermore, of the five patients with less than 40% UPDRS improvement, all but one had the majority of their VTA inside the STN. Conclusions: Our results are consistent with previous studies suggesting that therapeutic benefit is associated with electrode contacts near the dorsal border of the STN, and provide quantitative estimates of the electrical spread of the stimulation in a clinically relevant context.

24 January 2018 in Journal of Neural Engineering
Verified
Journal Article
Closed access
DBDavid M Brandman
David M Brandman
THTommy Hosman
Tommy Hosman
JSJad Saab
Jad Saab
Michael C. BurkhartMichael C. Burkhart
Michael C. Burkhart
BSBenjamin E Shanahan
Benjamin E Shanahan
LHLeigh R Hochberg
Leigh R Hochberg
Objective . Brain–computer interfaces (BCIs) can enable individuals with tetraplegia to communicate and control external devices. Though much progress has been made in improving the speed and robustness of neural control provided by intracortical BCIs, little research has been devoted to minimizing the amount of time spent on decoder calibration. Approach . We investigated the amount of time users needed to calibrate decoders and achieve performance saturation using two markedly different decoding algorithms: the steady-state Kalman filter, and a novel technique using Gaussian process regression (GP-DKF). Main results . Three people with tetraplegia gained rapid closed-loop neural cursor control and peak, plateaued decoder performance within 3 min of initializing calibration. We also show that a BCI-naïve user (T5) was able to rapidly attain closed-loop neural cursor control with the GP-DKF using self-selected movement imagery on his first-ever day of closed-loop BCI use, acquiring a target 37 s after initiating calibration. Significance . These results demonstrate the potential for an intracortical BCI to be used immediately after deployment by people with paralysis, without the need for user learning or extensive system calibration.